ALBANY MOLECULAR RESEARCH INC: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2016)
- $570.5M
- Net Income/Loss (FY2016)
- -$70.2M
- Total Assets (FY2016)
- $1.2B
- Total Equity (FY2016)
- $299.0M
- Cash Flows from Operating Activities (FY2016)
- $26.6M
Source: ALBANY MOLECULAR RESEARCH INC 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
